BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20662847)

  • 1. Novel therapeutic option for orbital atypical lymphoid hyperplasia.
    Talaulikar D; Tridgell D; Leong D; Dahlstrom JE; Cherian M; Prosser I; Sunderland K
    Clin Exp Ophthalmol; 2010 Dec; 38(9):892-4. PubMed ID: 20662847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term management of orbital and systemic reactive lymphoid hyperplasia with rituximab.
    Chen A; Hwang TN; Phan LT; McCulley TJ; Yoon MK
    Middle East Afr J Ophthalmol; 2012 Oct; 19(4):432-5. PubMed ID: 23248552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of benign orbital pseudolymphomas with the monoclonal anti-CD20 antibody rituximab.
    Witzig TE; Inwards DJ; Habermann TM; Dogan A; Kurtin PJ; Gross JB; Ananthamurthy A; Ristow KM; Garity JA
    Mayo Clin Proc; 2007 Jun; 82(6):692-9. PubMed ID: 17550749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy of lymphoproliferative diseases of the orbit. Surveillance of 65 cases.
    Keleti D; Flickinger JC; Hobson SR; Mittal BB
    Am J Clin Oncol; 1992 Oct; 15(5):422-7. PubMed ID: 1524043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of benign lymphoid hyperplasia of the orbit with rituximab.
    Ho HH; Savar A; Samaniego F; Manning J; Kasyan A; Pro B; Esmaeli B
    Ophthalmic Plast Reconstr Surg; 2010; 26(1):11-3. PubMed ID: 20090476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy of lymphoid diseases of the orbit.
    Austin-Seymour MM; Donaldson SS; Egbert PR; McDougall IR; Kriss JP
    Int J Radiat Oncol Biol Phys; 1985 Feb; 11(2):371-9. PubMed ID: 3918966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orbital lymphoproliferative and inflammatory lesions.
    White V; Rootman J; Quenville N; Worth A; Robertson W
    Can J Ophthalmol; 1987 Dec; 22(7):362-73. PubMed ID: 3325158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of cutaneous lymphoid hyperplasia with the monoclonal anti-CD20 antibody rituximab.
    Martin SJ; Duvic M
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11(3):286-8. PubMed ID: 21658657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult orbital xanthogranuloma successfully treated with rituximab.
    Satchi K; McNab AA; Godfrey T; Prince HM
    Ophthalmology; 2014 Aug; 121(8):1664-5.e1-3. PubMed ID: 24811966
    [No Abstract]   [Full Text] [Related]  

  • 10. Usefulness and limitations of rituximab in managing patients with lymphoproliferative disorder after heart transplantation.
    Senechal M; Demers S; Cantin B; Bourgault C; Leblanc MH; Morin J; Couture C
    Exp Clin Transplant; 2012 Oct; 10(5):513-8. PubMed ID: 22747415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tertiary lymphoid neogenesis is a component of pulmonary lymphoid hyperplasia in patients with common variable immunodeficiency.
    Maglione PJ; Ko HM; Beasley MB; Strauchen JA; Cunningham-Rundles C
    J Allergy Clin Immunol; 2014 Feb; 133(2):535-42. PubMed ID: 24131823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orbital presentation of posttransplantation lymphoproliferative disorder: a small case series.
    Douglas RS; Goldstein SM; Katowitz JA; Gausas RE; Ibarra MS; Tsai D; Sharma A; Nichols C
    Ophthalmology; 2002 Dec; 109(12):2351-5. PubMed ID: 12466183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of orbital lymphoid hyperplasia.
    Polito E; Leccisotti A
    Graefes Arch Clin Exp Ophthalmol; 1996 Mar; 234(3):150-4. PubMed ID: 8720713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytologic evaluation of lymphoproliferative lesions of the orbit/ocular adnexa: an analysis of 46 cases.
    Laucirica R; Font RL
    Diagn Cytopathol; 1996 Sep; 15(3):241-5. PubMed ID: 8955609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical idiopathic orbital inflammation in a young girl.
    Spindle J; Narang S; Purewal B; Shinder R
    Ophthalmic Plast Reconstr Surg; 2013; 29(3):e86-8. PubMed ID: 23247034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orbital lymphoproliferative tumors: analysis of clinical features and systemic involvement in 160 cases.
    Demirci H; Shields CL; Karatza EC; Shields JA
    Ophthalmology; 2008 Sep; 115(9):1626-31, 1631.e1-3. PubMed ID: 18440641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Waldenström macroglobulinemia of the orbit.
    Ranchod TM; Mansour TN; Fogt F; Gausas RE
    Ophthalmic Plast Reconstr Surg; 2008; 24(1):76-7. PubMed ID: 18209658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI patterns in orbital malignant lymphoma and atypical lymphocytic infiltrates.
    Akansel G; Hendrix L; Erickson BA; Demirci A; Papke A; Arslan A; Ciftci E
    Eur J Radiol; 2005 Feb; 53(2):175-81. PubMed ID: 15664279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraocular lymphoid tumors.
    Mittal BB; Deutsch M; Kennerdell J; Johnson B
    Radiology; 1986 Jun; 159(3):793-6. PubMed ID: 3704159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoid proliferations in the orbit: malignant or benign?
    van der Gaag R; Koornneef L; van Heerde P; Vroom TM; Pegels JH; Feltkamp CA; Peeters HJ; Gillissen JP; Bleeker GM; Feltkamp TE
    Br J Ophthalmol; 1984 Dec; 68(12):892-900. PubMed ID: 6391535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.